PATH Strangle Strategy

PATH (UiPath Inc.), in the Technology sector, (Software - Infrastructure industry), listed on NYSE.

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.

PATH (UiPath Inc.) trades in the Technology sector, specifically Software - Infrastructure, with a market capitalization of approximately $5.10B, a trailing P/E of 17.98, a beta of 0.91 versus the broader market, a 52-week range of 9.28-19.84, average daily share volume of 31.6M, a public-listing history dating back to 2021, approximately 4K full-time employees. These structural characteristics shape how PATH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.91 places PATH roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a strangle on PATH?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current PATH snapshot

As of May 15, 2026, spot at $10.38, ATM IV 95.94%, IV rank 75.21%, expected move 27.51%. The strangle on PATH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this strangle structure on PATH specifically: PATH IV at 95.94% is rich versus its 1-year range, which makes a premium-buying PATH strangle relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 27.51% (roughly $2.86 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PATH expiries trade a higher absolute premium for lower per-day decay. Position sizing on PATH should anchor to the underlying notional of $10.38 per share and to the trader's directional view on PATH stock.

PATH strangle setup

The PATH strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PATH near $10.38, the first option leg uses a $11.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PATH chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PATH shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$11.00$0.88
Buy 1Put$10.00$0.89

PATH strangle risk and reward

Net Premium / Debit
-$176.00
Max Profit (per contract)
Unbounded
Max Loss (per contract)
-$176.00
Breakeven(s)
$8.24, $12.76
Risk / Reward Ratio
Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

PATH strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on PATH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-99.9%+$823.00
$2.30-77.8%+$593.60
$4.60-55.7%+$364.21
$6.89-33.6%+$134.81
$9.19-11.5%-$94.59
$11.48+10.6%-$128.02
$13.77+32.7%+$101.38
$16.07+54.8%+$330.78
$18.36+76.9%+$560.18
$20.66+99.0%+$789.57

When traders use strangle on PATH

Strangles on PATH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PATH chain.

PATH thesis for this strangle

The market-implied 1-standard-deviation range for PATH extends from approximately $7.52 on the downside to $13.24 on the upside. A PATH long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current PATH IV rank near 75.21% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on PATH at 95.94%. As a Technology name, PATH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PATH-specific events.

PATH strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PATH positions also carry Technology sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PATH alongside the broader basket even when PATH-specific fundamentals are unchanged. Always rebuild the position from current PATH chain quotes before placing a trade.

Frequently asked questions

What is a strangle on PATH?
A strangle on PATH is the strangle strategy applied to PATH (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With PATH stock trading near $10.38, the strikes shown on this page are snapped to the nearest listed PATH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are PATH strangle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the PATH strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 95.94%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$176.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a PATH strangle?
The breakeven for the PATH strangle priced on this page is roughly $8.24 and $12.76 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PATH market-implied 1-standard-deviation expected move is approximately 27.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on PATH?
Strangles on PATH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PATH chain.
How does current PATH implied volatility affect this strangle?
PATH ATM IV is at 95.94% with IV rank near 75.21%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.

Related PATH analysis